Valentech Pharma Information

Valentech is a specialized Latin American healthcare company focused on enabling patient access to innovative therapies for high‑burden rare diseases across Central and South America. We partner with global biotech and pharmaceutical companies seeking a trusted regional ally to successfully launch and sustainably distribute highly innovative and orphan therapies in complex healthcare environments. Our core strength lies in navigating regulatory, reimbursement, and access barriers across diverse Latin American health systems. We have deep expertise in leveraging special access pathways for life‑threatening and orphan diseases, including early access, compassionate use, and other exceptional regulatory mechanisms, tailored to each territory in which we operate. Through this specialized approach, we ensure consistent patient access, strong therapeutic adherence, and long‑term treatment sustainability, translating innovation into real and measurable improvements in patients’ quality of life. At Valentech, we do not simply distribute therapies, we build access solutions that work in the real world for patients, healthcare systems, and our partners.